News Medical on MSN13 小时
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...
Medpage Today on MSN3 天
How Often Do Doctors Use New Weight-Loss Drugs in Kids?
As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...
Nutrition Business Journal Releases Special Report on Supplements in the Age of GLP-1 Agonists
BOULDER, CO / ACCESSWIRE / / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil a special report ...
News Medical on MSN5 天
GLP-1 agonists linked to fewer hospitalizations in alcohol use disorder patients
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...
New Research Helps Kick The Fat For Good
GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...
Daily3 天
GLP-1 receptor agonists may be effective in helping people drink less alcohol, finds study
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...
TCTMD6 天
Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key
In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community ...
Morningstar4 天
Nutrition Business Journal Releases Special Report on Supplements in the Age of GLP-1 Agonists
2024 / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil a special report highlighting how dietary supplements are complementary to the booming GLP-1 agonist drugs market.
Finanznachrichten4 天
New Hope Network: Nutrition Business Journal Releases Special Report on Supplements in the ...
2024 / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil a special report highlighting how dietary supplements are complementary to the booming GLP-1 agonist drugs market.